https://stemtimescaymanislands.com/article/864561905-normunity-announces-first-patient-dosed-in-phase-1-clinical-study-of-nrm-823-a-t-cell-engager-against-a-novel-tumor-specific-target-in-patients-with
Normunity announces first patient dosed in Phase 1 clinical study of NRM-823, a T Cell Engager...
t cell engagerin phaseclinical studyannouncesfirst
https://www.beacon-intelligence.com/events/beacon-t-cell-engager-europe/
Beacon | T-Cell Engager Europe
Sep 10, 2026 - Beacon will be exhibiting at the T-cell Engager Therapeutics Summit Europe on December 8-10th, 2026 in London,UK.
t cell engagerbeaconeurope
https://cell-engager-europe.com/about-event/
About | T-Cell Engager Therapeutics Summit Europe
Discover the mission, audience and scientific focus behind Europe’s premier T-cell engager summit driving innovation in immunotherapy research.
t cell engagertherapeuticssummiteurope